Endometrial thickness in tamoxifen-treated patients: An independent predictor of endometrial disease

Obstetrics and Gynecology

Volumn 93, Issue 6, 1999, Pages 1004-1008

  Franchi, Massimo ^a,b   Ghezzi, Fabio ^a   Donadello, Nicoletta ^a   Zanaboni, Flavia ^a   Beretta, Paolo ^a   Bous, Pierfrancesco ^a  

^a University of Iimibria   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; ENDOMETRIUM; ENDOMETRIUM BIOPSY; FEMALE; HUMAN; HUMAN TISSUE; HYSTEROSCOPY; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREDICTION; PRIORITY JOURNAL; THICKNESS; TRANSVAGINAL ECHOGRAPHY; VAGINA BLEEDING;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; ROC CURVE; TAMOXIFEN; TIME FACTORS; UTERINE DISEASES;

EID: 0033033841     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00561-4     Document Type: Article

References (21)

1. Clarke M, Collins R, Davies C, Godwin J, Gray R, Peto R. Tamoxifen for early breast cancer: An overview of the randomized trials. Lancet 1998;351:1451-67.
2. Cohen JC. Tamoxifen and endometrial cancer: Tamoxifen effects on the human female genital tract. Semin Oncol 1997;24:55-64.
3. Ugwumadu AHN, Carmichaels PL, Neven P. Tamoxifen and the femal genital tract. Int J Gynecol Cancer 1998;8:6-15.
4. Berliere M, Charles A, Galant C, Donnez J. Uterine side effects of tamoxifen: A need for systematic pretreatment screening. Obstet Gynecol 1998;91:40-4.
5. Cohen I, Rosen D, Tepper R, Cordoba M, Shapira Y, Altares M, et al. Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal patients treated with tamoxifen. J Ultrasound Med 1993;5:275-80.
6. Osmer R, Volksen M, Schauer A. Vaginosonography for early detection of endometrial carcinoma. Lancet 1990;335:1569-71.
7. Hulka CA, Hall DA. Endometrial abnormalities associated with tamoxifen therapy for breast cancer. Sonographic and pathologic correlations. Am J Roentgenol 1993;160:809-12.
8. Goldstein SR. Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen. Am J Obstet Gynecol 1994;170: 447-51.
9. DiSaia PJ, Creasman WT. Clinical gynecologic oncology. 5th ed. St. Louis, Missouri: Mosby, 1997.
10. Hann LE, Giess LE, Bach AM, Tao Y, Baum HJ, Barakat RR. Endometrial thickness in tamoxifen-treated patients. Correlation with clinical and pathologic findings. Am J Roentgenol 1997;168:657-81.
11. Kedar RP, Bourne TH, Powles TJ, Collins VVP, Ashley SE, Cosgrove DO, et al. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomized breast cancer preventional trial. Lancet 1994;343:1318-21.
12. Neven P, De Muylder X, Van Belle Y, Vanderick G, De Muylder E. Hysteroscopic follow-up during tamoxifen treatment. Eur J Obstet Gynecol Reprod Biol 1990;35:235-8.
13. Cheng WF, Lin HH, Torng PL, Huang SC. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients. Gynecol Oncol 1997;66:233-7.
14. Uziely B, Lewin A, Brufman A, Dorembus D, Mor-Yosef S. The effect of tamoxifen on the endometrium. Breast Cancer Res Treat 1993;26:101-5.
15. Cohen I, Altares MM, Shapira J, Tepper R, Rosen DJ, Cordoba M, et al. Time-dependent effect of tamoxifen therapy on endometrial pathology in asymptomatic postmenopausal breast cancer patients. Int J Gynecol Pathol 1996;15:152-7.
16. McGonigle KF, Shaw SL, Vasilev SA, Odom-Maryon T, Roy S, Simpson JF. Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal cancer patients may represent endometrial cystic atrophy. Am J Obstet Gynecol 1998; 178:1145-50.
17. Carlson RVV. Overview from a medical oncologist. Semin Oncol 1997:24(Suppl l):151-7.
18. Elkas }, Gray K, Howard L, Petit N, Fohl J, Armstrong A. The effect of tamoxifen on endometrial insulin-like growth factor-1 expression. Obstet Gynecol 1998;91:45-50.
19. Bourne TH, Lawton F, Leather A, Granberg S, Campbell S, Collins WP. Use of intracavitary saline instillation and transvaginal ultrasonography to detect tamoxifen associated endometrial polyps. Ultrasound Obstet Gynecol 1994;4:73-5.
20. Timmerman D, Deprest J, Bourne T, Van den Berghe I, Collins WP, Vergote I. A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen. Am J Obstet Gynecol 1998;179:62-70.
21. Nagele F, O'Connor H, Davies A, Badawy A, Mohamed H, Magos A. 2500 outpatient diagnostic hysteroscopies. Obstet Gynecol 1996; 88:87-92.